YU103A - Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju - Google Patents

Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju

Info

Publication number
YU103A
YU103A YU103A YUP103A YU103A YU 103 A YU103 A YU 103A YU 103 A YU103 A YU 103A YU P103 A YUP103 A YU P103A YU 103 A YU103 A YU 103A
Authority
YU
Yugoslavia
Prior art keywords
ppm
inert gas
solution
bottles
less
Prior art date
Application number
YU103A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Francois Dietlin
Daniele Fredj
Original Assignee
Pharmatop Scr.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8851012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmatop Scr. filed Critical Pharmatop Scr.
Publication of YU103A publication Critical patent/YU103A/sh

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Removal Of Specific Substances (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
YU103A 2000-06-06 2001-06-06 Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju YU103A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007231A FR2809619B1 (fr) 2000-06-06 2000-06-06 Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Publications (1)

Publication Number Publication Date
YU103A true YU103A (sh) 2006-05-25

Family

ID=8851012

Family Applications (1)

Application Number Title Priority Date Filing Date
YU103A YU103A (sh) 2000-06-06 2001-06-06 Postupak za dobijanje vodenih formulacija sa aktivnim sastojcima koji su osetljivi na oksidaciju

Country Status (16)

Country Link
US (1) US6992218B2 (fr)
CN (1) CN1556694A (fr)
AP (1) AP1880A (fr)
AU (1) AU2001266120A1 (fr)
CA (1) CA2415403C (fr)
CZ (1) CZ200313A3 (fr)
DZ (1) DZ3384A1 (fr)
FR (1) FR2809619B1 (fr)
MA (1) MA26926A1 (fr)
MX (1) MXPA03000001A (fr)
NZ (1) NZ523458A (fr)
PE (1) PE20030508A1 (fr)
RU (1) RU2003100090A (fr)
TW (1) TWI237570B (fr)
WO (1) WO2001093830A1 (fr)
YU (1) YU103A (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
US20050020554A1 (en) * 2003-06-06 2005-01-27 Ahmed Salah U. Stability of hormone formulations
JP2007505932A (ja) 2003-09-18 2007-03-15 マクサイト， インコーポレイテッド 経強膜送達
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
CA2597590A1 (fr) 2005-02-09 2006-08-17 Macusight, Inc. Formulations pour un traitement oculaire
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
KR101478164B1 (ko) 2006-02-09 2014-12-31 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
AU2007230964B2 (en) 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
RU2419421C2 (ru) 2006-07-18 2011-05-27 Хенфарма Лабораторио С.Л. Инъецируемая жидкая композиция парацетамола
EP1992334A1 (fr) * 2007-05-08 2008-11-19 Docpharma NV/SA Formule stable pour le stockage de médicament phénolique sensible à l'oxydation, spécialement le paracétamol, et qui comprend une solution de médicament aqueuse désoxygénée par le processus de fabrication à température contrôlée de la formule
DE102007026975A1 (de) * 2007-06-01 2008-12-04 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Antioxidationsmittel für Lebensmittel
AR067047A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
AR067048A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
JP5909750B2 (ja) 2007-11-13 2016-04-27 マリンクロット アイピー 低用量静脈内アセトアミノフェン
WO2009098716A2 (fr) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Compositions pharmaceutiques aqueuses stables
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
US20110097470A1 (en) * 2008-06-11 2011-04-28 Joerg Kowalczyk Highly active antioxidant based on trehalulose
EP2243477A1 (fr) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracétamol destiné à l'administration parentérale
EP2464332B2 (fr) 2009-08-13 2025-10-15 Neogen N.V. Procédé de production d'une formulation de paracétamol en solution aqueuse stable en stockage
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
JP5603873B2 (ja) * 2009-09-24 2014-10-08 株式会社東芝 炭酸ガス吸収液
WO2011071400A1 (fr) 2009-12-10 2011-06-16 Tecnimede - Sociedade Técnico-Medicinal, S.A. Procédé et composition pour préparation de formulations liquides stables de paracétamol
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
US9089477B2 (en) 2011-02-10 2015-07-28 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP3685827A1 (fr) 2011-03-04 2020-07-29 Grünenthal GmbH Formulation pharmaceutique aqueuse de tapentadol pour administration orale
ES2414557B1 (es) * 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
CN103006550A (zh) * 2012-12-11 2013-04-03 哈药集团三精制药股份有限公司 一种胞磷胆碱钠注射液及其制备方法
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
UY35988A (es) * 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
WO2016008546A1 (fr) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Formulation aqueuse comprenant du paracétamol et de l'ibuprofène
CN104288099B (zh) * 2014-09-25 2017-02-15 西安仁仁药业有限公司 一种布洛芬注射液的制备方法
JP6923447B2 (ja) * 2015-03-27 2021-08-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口投与のための安定な製剤
CU24523B1 (es) 2015-06-18 2021-06-08 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol
EP3701944B1 (fr) 2015-06-18 2021-12-08 Estetra SRL Unité posologique orodispersible contenant un composant d'estétrol
EP3120837A1 (fr) 2015-07-22 2017-01-25 Stada Arzneimittel Ag Solution de bortezomib prêts à l'emploi
SG11201806091YA (en) 2016-02-05 2018-08-30 Innopharma Inc Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation
EP3515412B1 (fr) 2016-09-23 2025-04-23 Grünenthal GmbH Formulation stable pour l'administration parentérale de tapentadol
WO2018140894A1 (fr) 2017-01-30 2018-08-02 Nevakar, Inc Compositions de norépinéphrine et procédés associés
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2018192664A1 (fr) * 2017-04-20 2018-10-25 Hyloris Developments Sa Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci
WO2019150381A1 (fr) * 2018-02-01 2019-08-08 Joshi Mahendra R Composition pharmaceutique stable et procédé de production d'une injection de chlorhydrate d'isoprotérénol
EP3781171B1 (fr) 2018-04-19 2022-02-09 Estetra SRL Composés et leurs utilisations pour soulager des symptômes associés à la ménopause
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CR20200552A (es) 2018-05-16 2021-05-13 Bayer Healthcare Llc Fórmula de suspención de alta concentración para medicamentos en cápsula de gel blanda paae resfriado y gripe
WO2020074419A1 (fr) * 2018-10-08 2020-04-16 Merz Pharma Gmbh & Co. Kgaa Flacon pré-rempli de neurotoxine
US10478453B1 (en) 2019-01-15 2019-11-19 Exela Pharma Sciences, LLC Stable, highly pure L-cysteine compositions for injection and methods of use
CA3174640A1 (fr) 2020-03-06 2021-09-10 Baxter International Inc. Systeme de recipient scelle conditionne de stockage stable de formulation pharmaceutique sensible a l'oxygene
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN113105040A (zh) * 2021-04-02 2021-07-13 武汉工控工业技术研究院有限公司 一种自然水体无菌处理及长期保存技术
CN116803376B (zh) * 2023-08-04 2024-02-13 广州白云山星群(药业)股份有限公司 一种复方愈创木酚磺酸钾口服溶液的制备方法
CN119745847A (zh) * 2025-01-10 2025-04-04 上海上药第一生化药业有限公司 一种盐酸多巴酚丁胺药组合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3443004A (en) * 1965-04-08 1969-05-06 Ciba Geigy Corp Injectable solution containing 6-chloroor 6-trifluoromethyl-7-sulfamyl - 1,2,4-benzothiodiazine-1,1-dioxide diuretic
DD153578A1 (de) * 1980-10-22 1982-01-20 Hans Meffert Stabilisierung von oxydationsempfindlichen wirkstoffen,vorrangig dithranol in arzneizubereitungen
RO93391B (ro) * 1984-12-20 1988-03-31 Eli Lilly And Company Procedeu pentru prepararea unor saruri de dobutamina
WO1994008602A1 (fr) * 1992-10-21 1994-04-28 Alcon Laboratories, Inc. Composition destinee a irriguer les tissus intraoculaires et a maintenir la mydriase lors d'une chirurgie intraoculaire
WO1994013274A1 (fr) * 1992-12-10 1994-06-23 Abbott Laboratories Solutions de catecholamines stabilisees
FR2740338B1 (fr) * 1995-12-01 1997-12-05 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant de la dobutamine
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention

Also Published As

Publication number Publication date
FR2809619B1 (fr) 2004-09-24
US20040054012A1 (en) 2004-03-18
CA2415403A1 (fr) 2001-12-13
FR2809619A1 (fr) 2001-12-07
CZ200313A3 (cs) 2003-11-12
WO2001093830A1 (fr) 2001-12-13
RU2003100090A (ru) 2004-05-10
MA26926A1 (fr) 2004-12-20
US6992218B2 (en) 2006-01-31
AP1880A (en) 2008-08-19
TWI237570B (en) 2005-08-11
CN1556694A (zh) 2004-12-22
NZ523458A (en) 2005-08-26
PE20030508A1 (es) 2003-06-25
MXPA03000001A (es) 2004-03-19
AU2001266120A1 (en) 2001-12-17
CA2415403C (fr) 2011-05-24
AP2002002711A0 (en) 2002-12-31
DZ3384A1 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
AP1880A (en) Method for obtaining aqueous formulations of oxidation sensitive active principles.
ES2216965T5 (es) Procedimiento de tratamiento y de extracción de compuestos orgánicos del corcho, mediante un fluido denso bajo presión
DE60206378D1 (de) Chlorogensäure enthaltender geschmacksmodifizierender stoff
CN108771961B (zh) 一种生物酶除甲醛剂及其应用
HRP20090350T1 (en) Injectable liquid paracetamol formulation
CN105746575A (zh) 一种缓释型固体二氧化氯制剂及其制备和使用方法
ITPD20130052A1 (it) Procedimento di vinificazione e prodotto per uso enologico atto ad essere utilizzato in detto procedimento di vinificazione
Mottram et al. Influence of ascorbic acid and pH on the formation of N‐nitrosodimethylamine in cured pork containing added dimethylamine
DE60003057D1 (de) Verfahren zur extraktion mit einem überkritischen fluid
ES2383438T3 (es) Procedimiento de tratamiento del corcho o de un material a base de corcho con un gas inerte a una presión estrictamente inferior a 1 Mpa
ATE301026T1 (de) Neue verfahren zur behandlung von korkstopfen und platten zur verringerung der fremden aromen, nämlich 2,4,6-trichoroanisole
ES2423255A1 (es) Procedimiento para la eliminación de haloanisoles y halofenoles presentes en el corcho e instalación para llevar a cabo dicha eliminación
HK1254526A1 (zh) 熏蒸系统及方法
KR20210041762A (ko) 식육의 수분조절 가공처리방법
Shih et al. Solvent sublation of hexachlorobutadiene and 2, 4, 6-trichlorophenol
EP0351145B1 (fr) Méthode d'imprégnation de bâtonnet de bois
ES2958166B2 (es) Método de tratamiento con agua activada por plasma de materiales auxiliares de origen forestal para la conservación del vino y uso del agua activada por plasma
RU2130743C1 (ru) Способ подготовительной обработки табачных листьев перед закладкой на хранение
Horvat et al. Effect of tannin addition on the efficacy of bentonite fining and the quality of Malvazija istarska (Vitis vinifera L.) wine
RU2134527C1 (ru) Способ предотвращения заплесневения табака
YAO et al. Effect of hyperbaric oxygen preconditioning on activation of plasma protein C in a rat model of asphyxial cardiac arrest-resuscitation
WO2001034355A3 (fr) Produit d'impregnation du bois
Orafidiya et al. Solution and colour stability of the bark extract of Bridelia ferruginea benth
CN106378838B (zh) 一种含有天然化合物的木材防腐剂
EP1911356B1 (fr) Procédé de préparation, conditionnement, conservation et diffusion à température ambiante de gélatines alimentaires pour nappages et nappages alimentaires